Lorenzo Rossi
0000-0001-6690-2064
Istituto Oncologico della Svizzera Italiana
3 papers found
Refreshing results…
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification
The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise review
Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?
Missing publications? Search for publications with a matching author name.